Antheia

Xinterra

This deep-tech company uses artificial intelligence and high-throughput experimentation to develop sustainable materials and formulations for industrial clients.

Anto

This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.

A-Alpha Bio

This deep-tech company provides protein interaction data and predictive models to pharmaceutical firms for the discovery and engineering of new medicines.

Granza Bio

This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.

Biosyntia

This company develops vitamins and plant-based active ingredients via microbial fermentation for customers in the nutrition, food, and beauty sectors.

Lantanabio

This company engineers yeast to produce plant compounds for use as ingredients in the food, beverage, dietary supplement and personal care industries.

ParcelBio

This deep-tech firm develops mRNA delivery technologies and programmable medicines for biotechnology and pharmaceutical organisations to treat autoimmune diseases and oncology.

Antiverse

This company uses generative AI to design functional antibody biologics for pharmaceutical organisations targeting complex medical conditions and transmembrane proteins.